CHMP Recommends 13 New Drugs for Approval, Including Two Orphan Meds

Drug Industry Daily
A A
The EMA’s Committee for Medicinal Products for Human Use (CHMP) flagged 13 medicines for approval at its April meeting, including two orphan medications and a biosimilar.

To View This Article:

Login

Subscribe To Drug Industry Daily